Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1980 1
1981 2
1982 7
1984 2
1985 2
1986 4
1989 2
1990 1
1991 4
1992 4
1993 4
1994 2
1995 4
1996 3
1998 2
1999 1
2000 9
2001 9
2002 6
2003 2
2004 7
2005 4
2006 5
2007 5
2008 5
2009 2
2010 2
2011 2
2013 2
2014 1
2017 2
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year
Filters applied: . Clear all
Page 1
Immunotherapy of superficial bladder cancer.
Shapiro A, Kadmon D, Catalona WJ, Ratliff TL. Shapiro A, et al. Among authors: kadmon d. J Urol. 1982 Nov;128(5):891-4. doi: 10.1016/s0022-5347(17)53265-6. J Urol. 1982. PMID: 6184490 Review. No abstract available.
Gene therapy for prostate cancer.
Gdor Y, Timme TL, Miles BJ, Kadmon D, Thompson TC. Gdor Y, et al. Among authors: kadmon d. Expert Rev Anticancer Ther. 2002 Jun;2(3):309-21. doi: 10.1586/14737140.2.3.309. Expert Rev Anticancer Ther. 2002. PMID: 12113054 Review.
The role of caveolin-1 in prostate cancer: clinical implications.
Thompson TC, Tahir SA, Li L, Watanabe M, Naruishi K, Yang G, Kadmon D, Logothetis CJ, Troncoso P, Ren C, Goltsov A, Park S. Thompson TC, et al. Among authors: kadmon d. Prostate Cancer Prostatic Dis. 2010 Mar;13(1):6-11. doi: 10.1038/pcan.2009.29. Epub 2009 Jul 7. Prostate Cancer Prostatic Dis. 2010. PMID: 19581923 Free PMC article. Review.
Therapeutic targets for metastatic prostate cancer.
Timme TL, Satoh T, Tahir SA, Wang H, Teh BS, Butler EB, Miles BJ, Amato RJ, Kadmon D, Thompson TC. Timme TL, et al. Among authors: kadmon d. Curr Drug Targets. 2003 Apr;4(3):251-61. doi: 10.2174/1389450033491127. Curr Drug Targets. 2003. PMID: 12643475 Review.
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC. Li L, et al. Among authors: kadmon d. Prostate Cancer Prostatic Dis. 2005;8(2):108-18. doi: 10.1038/sj.pcan.4500776. Prostate Cancer Prostatic Dis. 2005. PMID: 15724144 Review.
Influence of the neural microenvironment on prostate cancer.
Coarfa C, Florentin D, Putluri N, Ding Y, Au J, He D, Ragheb A, Frolov A, Michailidis G, Lee M, Kadmon D, Miles B, Smith C, Ittmann M, Rowley D, Sreekumar A, Creighton CJ, Ayala G. Coarfa C, et al. Among authors: kadmon d. Prostate. 2018 Feb;78(2):128-139. doi: 10.1002/pros.23454. Epub 2017 Nov 13. Prostate. 2018. PMID: 29131367 Free PMC article.
The role of caveolin-1 in androgen insensitive prostate cancer.
Mouraviev V, Li L, Tahir SA, Yang G, Timme TM, Goltsov A, Ren C, Satoh T, Wheeler TM, Ittmann MM, Miles BJ, Amato RJ, Kadmon D, Thompson TC. Mouraviev V, et al. Among authors: kadmon d. J Urol. 2002 Oct;168(4 Pt 1):1589-96. doi: 10.1097/01.ju.0000030164.80605.b9. J Urol. 2002. PMID: 12352463 Review.
In situ gene therapy for prostate cancer: immunomodulatory approaches.
Thompson TC, Timme TL, Ebara S, Satoh T, Yang G, Wang J, Miles BJ, Ayala G, Wheeler TM, Kadmon D. Thompson TC, et al. Among authors: kadmon d. Expert Opin Biol Ther. 2001 May;1(3):481-95. doi: 10.1517/14712598.1.3.481. Expert Opin Biol Ther. 2001. PMID: 11727520 Review.
106 results